Unlock stock picks and a broker-level newsfeed that powers Wall Street.
HKSE - Delayed Quote HKD

JBM (Healthcare) Limited (2161.HK)

Compare
1.740
-0.040
(-2.25%)
At close: April 3 at 3:58:32 PM GMT+8
Loading Chart for 2161.HK
  • Previous Close 1.780
  • Open 1.780
  • Bid 1.740 x --
  • Ask 1.760 x --
  • Day's Range 1.730 - 1.780
  • 52 Week Range 0.860 - 2.090
  • Volume 456,000
  • Avg. Volume 838,515
  • Market Cap (intraday) 1.416B
  • Beta (5Y Monthly) 0.16
  • PE Ratio (TTM) 8.70
  • EPS (TTM) 0.200
  • Earnings Date --
  • Forward Dividend & Yield 0.11 (6.32%)
  • Ex-Dividend Date Dec 17, 2024
  • 1y Target Est 2.42

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other non-pharmaceutical products for the general health and wellness of consumers. The company also offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong.

www.jbmhealthcare.com.hk

279

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 2161.HK

View More

Performance Overview: 2161.HK

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2161.HK
8.42%
HANG SENG INDEX (^HSI)
13.91%

1-Year Return

2161.HK
107.90%
HANG SENG INDEX (^HSI)
36.62%

3-Year Return

2161.HK
126.63%
HANG SENG INDEX (^HSI)
3.68%

5-Year Return

2161.HK
17.57%
HANG SENG INDEX (^HSI)
1.66%

Compare To: 2161.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2161.HK

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    1.42B

  • Enterprise Value

    1.35B

  • Trailing P/E

    8.91

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.03

  • Price/Book (mrq)

    1.40

  • Enterprise Value/Revenue

    1.87

  • Enterprise Value/EBITDA

    6.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.74%

  • Return on Assets (ttm)

    8.54%

  • Return on Equity (ttm)

    16.25%

  • Revenue (ttm)

    720.54M

  • Net Income Avi to Common (ttm)

    163.88M

  • Diluted EPS (ttm)

    0.200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    189.67M

  • Total Debt/Equity (mrq)

    8.32%

  • Levered Free Cash Flow (ttm)

    205.48M

Research Analysis: 2161.HK

View More

Company Insights: 2161.HK

Research Reports: 2161.HK

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.